Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 40 out of 100. End-of-life care

Topic: Risk, prevention and care in population studies

Plain-language summary

After screening, a total of 48 studies were included in this review. Results indicate a great variability in the place of death of people with dementia across different regions and settings. Overall, in Europe and North America, it was more common for people with dementia to die in long-term care facilities like care homes, nursing homes, and sheltered housing; in East Asia and the Pacific, medical facilities (i.e., hospitals, mental health facilities, and private clinics) were more common. Studies that showed trends also indicate an increase in long-term-care facilities and a decrease in medical facilities and homes as the place of death. Most studies were conducted in high-income countries, raising questions about the diverse factors that may influence the place of death, such as access to services and socioeconomic status. These results could inform decisions on allocating resources and training for end-of-life care for people with dementia. However, more research is needed to increase the representativeness of other world regions and understand other variables that influence the place of death.

What this study adds

Evidence grade: Low

The record lists 48 participants. This scoping review of 48 studies found wide variation in where people with dementia die, with long-term care facilities more common in Europe and North America and medical facilities more common in East Asia and the Pacific. It concerns place of death, not treating, curing or preventing Alzheimer's disease.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Hidalgo-Andrade, P., Unda‐López, A., & Pastrana, T. (2026). Place of death for people with dementia: A scoping review. PLoS ONE. https://doi.org/10.1371/journal.pone.0340024

Vancouver

Hidalgo-Andrade P, Unda‐López A, Pastrana T. Place of death for people with dementia: A scoping review. PLoS ONE. 2026. doi:10.1371/journal.pone.0340024. PMID: 41511992.

BibTeX

@article{hidalgoandrade2026-41511992,
  author  = {Hidalgo-Andrade, Paula and Unda‐López, Alejandro and Pastrana, Tania},
  title   = {{Place of death for people with dementia: A scoping review}},
  journal = {PLoS ONE},
  year    = {2026},
  doi     = {10.1371/journal.pone.0340024},
  pmid    = {41511992},
  url     = {https://doi.org/10.1371/journal.pone.0340024}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

This scoping review of 48 studies found wide variation in where people with dementia die, with long-term care facilities more common in Europe and North America and medical facilities more common in East Asia and the Pacific. It concerns place of death, not treating, curing or preventing Alzheimer's disease.

Study details

How this study scored 40/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 4 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 5 of 5; Sample size 1 of 4; Effect reported 0 of 3; Studied in people 3 of 3; Randomized / blinded 0 of 2; Times cited 1 of 7; Citations per year 0 of 5; Impact for its field and year 0 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 2 of 4; Institution's track record 1 of 3; Multicenter collaboration 1 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 40 of 100.40 of 100 points earned60 not earned

Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (PLoS ONE)
Journal's citation record 4 / 4 PLoS ONE: journal h-index 594 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 1 / 4 48 participants
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 1 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.5 citations a year over 2 year(s) since 2026
Impact for its field and year 0 / 6 Cited 0.0× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Tania Pastrana: h-index 23 (OpenAlex, whole career)
Institution's track record 1 / 3 RWTH Aachen University: institution h-index 959 (OpenAlex)
Multicenter collaboration 1 / 3 OpenAlex lists 2 institution(s) in 2 countries
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 41511992)
Free to read 2 / 2 Free to read
Total 40 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 13.

Related studies in End-of-life care from nearby years

Also tagged “nursing”

995 studies in the library carry the topic tag “nursing”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 995 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on End-of-life care

See all studies in End-of-life care →